Literature DB >> 23220498

Killer cell immunoglobulin-like receptor genes in four human West Nile virus infections reported 2011 in the Republic of Macedonia.

Mirko Spiroski1, Zvonko Milenkovic, Aleksandar Petlichkovski, Ljubomir Ivanovski, Irena Kondova Topuzovska, Eli Djulejic.   

Abstract

West Nile virus (WNV) is a neurotropic, arthropod-borne flavivirus that is maintained in an enzootic cycle between mosquitoes and birds, but can also infect and cause disease in horses and humans. The aim of this study was to examine KIR gene polymorphisms by determining the frequencies of 16 KIR genes and pseudogenes and KIR genotypes in Macedonian patients with West Nile virus infection, and to compare with healthy Macedonians. The studied sample consists Republic of Macedonia, hospitalized at the University Clinic of Infective Diseases between September 2011 and October 2011, and reported through WHO. For KIR genotyping, commercially available PEL-FREEZ KIR genotyping SSP kit (Dynal Biotech, Brown Deer, WI) was used. The population genetics analysis package, Arlequin, was used for analysis of the data. We found that all 16 KIR genes were observed in the studied individuals and framework genes (KIR3DL3, KIR3DP1, KIR2DL4, and KIR3DL2) were present in all individuals. Comparison of KIR frequencies between Macedonian patients with West Nile virus infection and healthy Macedonian population reveals several significant differences in the inhibitory group (KIR2DL2), and in the non inhibitory group (KIR2DS1, KIR2DS2, KIR2DS5, and KIR3DS1). The single most frequent genotypes in the Bx group were genotypes ID71 and ID89 with statistically significant difference compared to healthy Macedonians. Our results suggest that specific KIR genotypes could be connected with West Nile virus infection.
Copyright © 2012 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23220498     DOI: 10.1016/j.humimm.2012.11.015

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  5 in total

1.  Association between high expression macrophage migration inhibitory factor (MIF) alleles and West Nile virus encephalitis.

Authors:  Rituparna Das; Kerry Loughran; Charles Murchison; Feng Qian; Lin Leng; Yan Song; Ruth R Montgomery; Mark Loeb; Richard Bucala
Journal:  Cytokine       Date:  2015-11-28       Impact factor: 3.861

2.  Genetic Contribution of MHC Class II Genes in Susceptibility to West Nile Virus Infection.

Authors:  Constantina A Sarri; Maria Markantoni; Costas Stamatis; Anna Papa; Athanasios Tsakris; Danai Pervanidou; Agoritsa Baka; Constantina Politis; Charalambos Billinis; Christos Hadjichristodoulou; Zissis Mamuris
Journal:  PLoS One       Date:  2016-11-03       Impact factor: 3.240

3.  Genetics in Macedonia-Following the international trends.

Authors:  Elena Sukarova-Angelovska; Aleksandar Petlichkovski
Journal:  Mol Genet Genomic Med       Date:  2018-02-20       Impact factor: 2.473

4.  Identification of genetic variants associated with dengue or West Nile virus disease: a systematic review and meta-analysis.

Authors:  Megan E Cahill; Samantha Conley; Andrew T DeWan; Ruth R Montgomery
Journal:  BMC Infect Dis       Date:  2018-06-22       Impact factor: 3.090

5.  Lack of association of the KIR and HLA class I ligands with ZIKV infection in south and southeast of Brazil.

Authors:  Laise Nayana Sala Elpidio; Amarilis Giaretta de Moraes; Ieda Bernadete Volkweis Langer; Greicy Cezar do Amaral; Maria Luiza Moretti; Márcia Teixeira Garcia; Rodrigo Angerami; José Luiz Proenca-Modena; Karina Bispo-Dos-Santos; Matheus Cavalheiro Martini; Pierina Lorencini Parise; Christiane Maria Ayo; Luiz Carlos de Mattos; Cinara Cássia Brandão; Maurício Lacerda Nogueira; Denise Cristina Mós Vaz Oliani; Lígia Cosentino Junqueira Franco Spegiorin; Quirino Alves de Lima Neto; Jeane Eliete Laguila Visentainer
Journal:  Mem Inst Oswaldo Cruz       Date:  2022-08-15       Impact factor: 2.747

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.